Using circulating biomarkers to stage hepatocellular carcinoma: Pitfalls and limitations. Huo TI, Liu PH, Hsu CY. Hepatology 2020 Nov 10. doi: 10.1002/hep.31618.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huo TI, Liu PH, Hsu CY. Using circulating biomarkers to stage hepatocellular carcinoma: Pitfalls and limitations. Hepatology 2020 Nov 10. doi: 10.1002/hep.31618.
PMID: 33170973